49.17
price up icon4.88%   2.29
after-market Handel nachbörslich: 49.17
loading

Finanzdaten der Soleno Therapeutics Inc-Aktie (SLNO)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
68.76%
23.48
13.91 10.38 8.623 8.469
Depreciation and Amortization
0.20%
0.49
0.489 0.49 0.489 0.49
Operating Income/Loss
68.76%
-23.48
-13.91 -10.38 -8.623 -8.469
Nonoperating Income/Loss
20.54%
2.077
2.614 -0.479 0.148 0.113
Income/Loss From Continuing Operations Before Tax
89.43%
-21.40
-11.30 -10.86 -8.475 -8.356
Income/Loss From Continuing Operations After Tax
89.43%
-21.40
-11.30 -10.86 -8.475 -8.356
Net Income/Loss
89.43%
-21.40
-11.30 -10.86 -8.475 -8.356
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
498.59%
36.21
6.0489 11.44 10.42 9.4474
Diluted Average Shares
498.59%
36.21
6.0489 11.44 10.42 9.4474
Basic Earnings Per Share
303.45%
-0.59
0.29 -0.95 -0.81 -0.88
Diluted Earnings Per Share
303.45%
-0.59
0.29 -0.95 -0.81 -0.88
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$21.80
price up icon 4.81%
$73.47
price up icon 2.14%
$22.10
price up icon 16.13%
$367.97
price up icon 2.52%
biotechnology ONC
$218.70
price up icon 4.10%
$117.25
price up icon 4.75%
Kapitalisierung:     |  Volumen (24h):